The Thromboxane/Prostacyclin Balance in Guinea Pig Cochlea



Thromboxane and prostacyclin as metabolites of arachidonic acid are substances with opposite effects. While the first acts vasoconstrictively and is accumulated in impaired tissue, the latter is attributed as cytoprotective, vasodilative substance. They represent the opposite pole of the same homeostatic mechanism and their ratio reflects the viability and responsiveness of the corresponding tissue to stimuli, such as hypoxia, vascular impairment or metabolic changes (Oates and Fitz- Gerals, 1985). The balance between thromboxane and prostacyclin can be selectively influenced by drugs favouring the last (Deckmyn et al., 1983). This is also possible in the vital cochlea where these substances can cross the blood-labyrinth barrier (Ernst et al., 1987). Although the involvement of prostanoids in drug ototoxicity affecting the hair cells is hardly credible (Schacht, 1986), it remains tempting to speculate on changes of eicosanoids linked to alterations of the non-sensory tissue caused by either noise or e.g. loop diuretics (McFadden, 1986; Rybak et al., 1986). It was demonstrated by Tachibana and Nishimura (1986) that precursors of arachidonic acid are preferably incorporated in non-sensory cochlear structures, i.e. stria vascularis and spiral ligament. These findings correspond to what was found in the CNS (Keller et al., 1985).


Arachidonic Acid Noise Exposure Stria Vascularis Endocochlear Potential Spiral Ligament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anniko, M. and Wroblewski, R., 1986, Ionic environment of cochlear hair, cells, Hearing Res., 22:279–293.CrossRefGoogle Scholar
  2. Bevan, S. and Wood, J. N., 1987, Arachidonic-acid metabolites as second messengers, Nature (London), 328:20.PubMedCrossRefGoogle Scholar
  3. Deckmyn, H., van Houtte, E., Verstraete, M. and Vermylen, J., 1983, Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds Dazoxiben, Acetylsalicylic acid, and Nafazatrom, Biochem. Pharmacol., 32:2757–2762.PubMedCrossRefGoogle Scholar
  4. Escoubet, B., Amsallem, P., Ferrary, E. and Tran Ba Huy, P., 1985, Prostaglandin synthesis by the cochlea of the guinea pig, Prostaglandins, 19:589–599.CrossRefGoogle Scholar
  5. Ernst, A., Lotz, P. and Mest, H.-J., 1987, PGI2/TXA balance in guinea pig perilymph, in: “Cochlea Symposion 87”, L.-P. Lobe and P. Lotz, eds., Halle University Press (in press).Google Scholar
  6. Ernst, A., Taube, Ch., Lotz, P. and Mest, H.-J., 1988, Dazoxiben changes the thromboxane/prostacyclin balance in the lateral cochlear wall, Arch. Otorhinolaryngol. (in press).Google Scholar
  7. McFadden, D., 1986, Some issues associated with interactions between ototoxic drugs and exposure to intense sound, in: “Basic and applied aspects of noise-induced hearing loss”, R. J. Salvi, D. Henderson, R. P. Hamernik and V. Coletti, eds., Plenum, New York, 541–550.Google Scholar
  8. Forge, A., 1986, The morphology of the normal and pathological cell membrane and junctional complexes of the cochlea, Ibid., 55–68.Google Scholar
  9. Gratacap, B., Characon, R. and Stoebner, P., 1985, Results of an ultra- structural study comparing stria vascularis with organ of Corti in guinea pigs treated with Kanamycin, Acta Oto-laryngol., 99:339–342.CrossRefGoogle Scholar
  10. Henson, M. M., Burridge, K., Fitzpatrick, D., Jenkins, D. B., Pillsbury, H. C. and Henson jr., O. W., 1985, Immunocytochemical localization of contractile and contraction-associated proteins in the spiral ligament of the cochlea, Hearing Res., 20:207–214.CrossRefGoogle Scholar
  11. Ikeda, K., Kusakari, J., Takasaka, T. and Saito, Y., 1987, The Ca2+ activity of cochlear endolymph of the guinea pig and the effect of inhibitors, Hearing Res., 26:117–125.CrossRefGoogle Scholar
  12. Juhn, S. K., Rybak, L. P. and Jung, T. T. K., 1985, Transport characteristics of the blood-labyrinth barrier, in: “Auditory Biochemistry”, D. G. Drescher and J. E. Medina, eds., Thomas, Springfield, 488–499.Google Scholar
  13. Keller, M., Jackisch, R., Seregi, A. and Hertting, G., 1985, Comparison of prostanoid forming capacity of neuronal and a stroglial cells in primary cultures, Neurochem. Int., 7:655–665.PubMedCrossRefGoogle Scholar
  14. Lotz, P., Posse, D., Haberland, E.-J., Kuhl, K.-D. and Ernst, A., 1986, The metabolic reaction of the cochlea to unphysiological noise exposure, Acta Oto-laryngol., 102:20–26.CrossRefGoogle Scholar
  15. Majerus, P. W., Connolly, T. M., Deckmyn, H., Ross, T. S., Bross, E. E., Ishii, H., Bansal, V. S. and Wilson, D. B., 1986, The metabolism of phosphoinositide-derived messenger molecules, Science, 234:1519–1526.PubMedCrossRefGoogle Scholar
  16. Nuttall, A. L., LaRouere, M. J. and Lawrence, M., 1982, Acute perilymphatic perfusion of the guinea pig cochlea, Hearing Res., 6:207–221.CrossRefGoogle Scholar
  17. Oates, J. A., FitzGerals, G. A., 1985, Endogenous Biosynthesis of prostacyclin and thromboxane A2 and the prevention of Vascular Occlusion in man, in: “Prostacyclin — Clinical Trials”, R. J. Gryglowski, ed., Raven, New York, 115–123.Google Scholar
  18. Renkawek, K., Herbaczynska-Cedro, K. and Mossakowski, M. J., 1986, The effect of prostacyclin on the morphological and enzymatic properties of CNS cultures exposed to anoxia, Acta Neurol. Scand., 73:111–118.PubMedCrossRefGoogle Scholar
  19. Rybak, L. P., Santiago, W. and Whitworth, C., 1986, An experimental study using sodium salicylate to reduce cochlear changes induced by furosemide, Arch. Otorhinolaryngol., 243:180–182.PubMedCrossRefGoogle Scholar
  20. Rybak, L. P. and Whitworth, C., 1987, Some organic acids attenuate the effects of furosemide on the endocochlear potentials, Hearing Res., 26:89–93.CrossRefGoogle Scholar
  21. Schacht, J., 1986, Molecular mechanisms of drug-induced hearing loss, Hearing Res., 22:297–304.CrossRefGoogle Scholar
  22. Schror, K., 1986, Prostaglandins and other fatty acid peroxidation products in cerebral ischemia, in: “Pharmacology of cerebral ischemia”, J. Krieglstein, ed., Elsevier, Amsterdam, 199–209.Google Scholar
  23. Seregi, A., Keller, M. and Hertting, G., 1987, Are cerebral prostanoids of astroglial origin?, Brain Res., 404:113–120.PubMedCrossRefGoogle Scholar
  24. Tachibana, M. and Nishimura, H., 1986, Incorporation of inositol in the cochlear tissues as determined by autoradiography, Hearing Res., 24:105–109.CrossRefGoogle Scholar
  25. Taube, Ch., Hoffmann, P. and Forster, W., 1982, Enhanced thromboxane production in the aorta of spontaneously hypertensive rats in vitro, Prostagl. Leukotr. Med., 9:411–414.CrossRefGoogle Scholar
  26. Tran Ba Huy, P., Ferrary, E., Escoubet, B. and Sterkers, O., 1987, Strial Prostaglandins and leukotrienes, Acta otolaryngol., 103:558–567.PubMedGoogle Scholar
  27. Watanabe, K., 1986, Ultrastructural characteristics of capillaries entering and leaving the stria vascularis, Ann. Otol. Rhinol. Laryngol., 95:309–312.PubMedGoogle Scholar
  28. Yoshibara, T. and Igarashi, M., 1987, Cytochemical localization of Ca2+- ATPase activity in the lateral cochlear wall of the guinea pig, Arch. Otorhinolaryngol., 243:395–400.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  1. 1.ENT ClinicMartin Luther UniversityHalle/SaaleGermany
  2. 2.Dept. Pharmacology and ToxicologyMartin Luther UniversityHalle/SaaleGermany

Personalised recommendations